種子の遺伝情報の私的所有はどのように正当化されてきたのか : ─農業遺伝資源関連の諸制度における所有領域と正当化の考察─
スポンサーリンク
概要
- 論文の詳細を見る
With the advance of genetic modification (GM) technology, there has been a trend towards trade in genetic information. However, considering genetic information as vital information, there are questions over whether it is appropriate to treat it as a tradable good. In other words, such trade raises ethical questions regarding the control and utilization of genetic information.To study these ethical questions, it is first necessary to clarify the problems relating to property of genetic information. This article studies a case involving seeds for agricultural use, and will critically examine the relevant legal system and previous arguments from the viewpoint of the justification of private property. This study has resulted in indicating three new points.First, property of genetic information has become an issue due to the use of GM technology in plant breeding. The genetic information is considered to be a tradable good separate from the seed itself, leading to a situation in which a seed = matter + genetic information. From an analysis of the legal system, it is clear that genetic information can be considered private property.Second, an analysis of prior discussion has shown that the notion of genetic information as private property is regarded as a self-evident truth in economic studies of the issue. This has resulted in avoidance of discussion on any values other than economic efficiency and the initial allocation of goods.Third, by critically reviewing previous discussion from a viewpoint of regarding genetic information as vital information, it became clear that genetic information has unique points when compared with other economic goods.In conclusion, the justification of property rights of genetic information should be reexamined from the viewpoint of the fundamental principles of property rights and the uniqueness of genetic information.
論文 | ランダム
- 0694 各種女性ホルモンの誘導性NO合成酵素合成抑制作用機構の検討
- アメリカにおける「患者の死ぬ権利」の現状--Advance Directiveに焦点を当てて (特集:海外における社会福祉をめぐる新しい動き)
- アルツハイマー型痴呆, ダウン症患者の抗コリン剤点眼に対する散瞳過敏反応
- 生物学的年齢の評価と指標
- 0321 動脈硬化退縮病変でNO分泌反応は回復するか : 誘導性NO合成酵素との関連